Beacon Webinars
Welcome to our comprehensive webinar resource page, your gateway to invaluable insights and expertise across our Beacon modalities. Here, you’ll find a collection of on-demand webinars, each thoughtfully crafted and delivered by our expert team. These webinars provide an abundant amount of commercial and research insights that serve to support your investment and drug development decisions.
Home > Webinar Resources
Upcoming Webinars
Watch Our Previous Sessions On Demand

Webinar – The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape

Webinar – Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far

Webinar – Gene Therapy: Optimizing the Safety of Viral Vectors

Webinar – The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates

Webinar – Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis

Webinar – Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond

Webinar – Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases

Webinar – T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications

Webinar – The TPD Disease Landscape: Oncology vs. Non-Oncology

Webinar – The DDR Landscape: The Past, Present & Future
Additional Content

DDR: 2024 Landscape Review

VEGFxPD-(L)1 Multispecifics Report

Cancer Vaccine: 2024 Landscape Review

Checkpoint: 2024 Landscape Review

Microbiome: 2024 Landscape Review

Cytokine: 2024 Landscape Review

Oncolytic Viruses: 2024 Landscape Review

Immune Tolerance: 2024 Landscape Review

TPD: 2024 Landscape Review

Bispecific: 2024 Landscape Review

RNA: 2024 Landscape Review

ADC: 2024 Landscape Review
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.